Visual Pharma by Powtoon has been named a finalist in the 2026 LTEN Excellence Awards in the category of Innovative Design & Solutions, recognizing its work in advancing scientific communication ...
Effect of low FGFR3 but high CD8 T cell infiltrated immune micro-environment on treatment response with pembrolizumab in upper tract urothelial carcinoma. Effects of supervised exercise and ...
– Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart – – Recruitment ongoing for Phase 1b study of intravenously-administered ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Meliora Therapeutics, a biotech company pioneering a machine learning-driven platform to decipher oncology drugs’ true mechanisms-of-action, announced today the ...
– Recruitment ongoing for Phase 1b study of intravenously-administered rademikibart designed to further confirm its unique ability to rapidly improve airway function with topline results expected in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results